Finally, we checked whether this TOM1L1 invasive role was conserved in breast tumour cells by overexpressing TOM1L1 in the ERBB2- and TOM1L1-negative breast cancer cell line MDA-MB-231 (Supplementary Fig. 6). This evidence concerns the gene ERBB2 and breast cancer.